Updated estimates of neural tube defects prevented by mandatory folic acid fortification — United States, 1995–2011

Morbidity and Mortality Weekly Report

Volumn 64, Issue 1, 2015, Pages 1-5

  Williams, Jennifer ^a   Mai, Cara T ^a   Mulinare, Joe ^a   Isenburg, Jennifer ^a,b   Flood, Timothy J ^c   Ethen, Mary ^d   Frohnert, Barbara ^e   Kirby, Russell S ^f  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b Carter Consulting Inc   (United States)

^c ARIZONA DEPARTMENT OF HEALTH SERVICES   (United States)

^d TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

^e MINNESOTA DEPARTMENT OF HEALTH   (United States)

^f UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

AFRICAN AMERICAN; ANENCEPHALY; CAUCASIAN; DIET SUPPLEMENTATION; FEMALE; HEALTH CARE POLICY; HEALTH SURVEY; HISPANIC; HUMAN; NEWBORN; PREGNANCY; SPINAL DYSRAPHISM; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AFRICAN AMERICANS; ANENCEPHALY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLIC ACID; FOOD, FORTIFIED; HEALTH POLICY; HISPANIC AMERICANS; HUMANS; INFANT, NEWBORN; POPULATION SURVEILLANCE; PREGNANCY; SPINAL DYSRAPHISM; UNITED STATES;

EID: 84922447495     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Note

References (10)

1. CDC. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep 1992; 41(No. RR-14).
2. CDC. CDC Grand Rounds: additional opportunities to prevent neural tube defects with folic acid fortification. MMWR Morbid Mortal Wkly Rep 2010; 59: 980-4.
3. CDC. Spina bifida and anencephaly before and after folic acid mandate-United States, 1995-1996 and 1999-2000. MMWR Morbid Mortal Wkly Rep 2004; 53: 362-5.
4. Grosse SD, Ouyang L, Collins JS, Green D, Dean JH, Stevenson RE. Economic evaluation of a neural tube defect recurrence-prevention program. Am J Prev Med 2008; 35: 572-7.
5. Pfeiffer CM, Hughes JP, Lacher DA, et al. Estimation of trends in serum and RBC folate in the United States population from pre-to post-fortification using assay-adjusted data from the NHANES 1988-2010. J Nutr 2012; 142: 886-93.
6. Crider KS, Devine O, Hao L, et al. Population red blood cell folate concentrations for prevention of neural tube defects: Bayesian model. BMJ 2014; 349: g4554.
7. Tinker SC, Hamner H, Crider KS. Red blood cell folate concentrations among non-pregnant United States women of childbearing age, National Health and Nutrition Examination Survey, 2007-2010. Available at http://epiresearch. org/wp-content/uploads/2014/08/abstract-book-printed. pdf.
8. Tinker SC, Cogswell ME, Devine O, Berry RJ. Folic acid intake among United States women aged 15-44 years, National Health and Nutrition Examination Survey, 2003-2006. Am J Prev Med 2010; 38: 534-42.
9. Crider KS, Zhu JH, Ling H, et al. MTHFR 677C→T genotype is associated with folate and homocysteine concentrations in a large population-based, double blind trial of folic acid supplementation. Am J Clin Nutr 2011; 93: 1365-72.
10. Tinker SC, Devine O, Mai C, et al. Estimate of the potential impact of folic acid fortification of corn masa flour on the prevention of neural tube defects. Birth Defects Res A Clin Mol Teratol 2013; 97: 649-57.